11.64 0 (0%) | 06-17 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 17.52 ![]() |
1-year : | 20.46 ![]() |
Resists | First : | 15 ![]() |
Second : | 17.52 ![]() |
Pivot price | 13.19 ![]() |
|||
Supports | First : | 12.92 ![]() |
Second : | 11.64 ![]() |
MAs | MA(5) : | 13.18 ![]() |
MA(20) : | 13.25 ![]() |
MA(100) : | 12.84 ![]() |
MA(250) : | 12.09 ![]() |
|
MACD | MACD : | -0.2 ![]() |
Signal : | -0.2 ![]() |
%K %D | K(14,3) : | 47.6 ![]() |
D(3) : | 50 ![]() |
RSI | RSI(14): 57.2 ![]() |
|||
52-week | High : | 15.5 | Low : | 11.4 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TLGY ] has closed Bollinger Bands are 26.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 12.76 - 12.82 | 12.82 - 12.88 |
Low: | 12.6 - 12.67 | 12.67 - 12.73 |
Close: | 12.64 - 12.75 | 12.75 - 12.85 |
TLGY Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on targets in biopharma or technology enabled business-to-consumer industries worldwide. The company was incorporated in 2021 and is based in Wilmington, Delaware.
Fri, 30 May 2025
Saylor’s Contrarian Bet Morphs Into Crypto Gold Rush - Bloomberg.com
Wed, 09 Apr 2025
TLGY Acquisition Explores Partnership with Ethena Foundation - TipRanks
Wed, 20 Nov 2024
TLGY Stock Soars to All-Time High, Reaching $11.65 - Investing.com
Thu, 20 Jun 2024
TLGY Acquisition Corp. Undergoes Major Restructuring and Leadership Shake-Up - TipRanks
Wed, 08 May 2024
TLGY Acquisition Pushes Verde Deadline Back a Month - The SPAC Conference
Thu, 21 Mar 2024
Bioplastics player Verde Bioresins terminates SPAC deal - Packaging Dive
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Financial Services
|
|
Industry:
Shell Companies
|
|
Shares Out | 4 (M) |
Shares Float | 4 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 97.7 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0.15 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | -0.93 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -1.7 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -2 (M) |
Levered Free Cash Flow | -1 (M) |
PE Ratio | 86.87 |
PEG Ratio | 0 |
Price to Book value | -15.11 |
Price to Sales | 0 |
Price to Cash Flow | -32.94 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |